None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Healthy adult volunteers of either sex aged between >= 18 to 2. Subjects willing to sign informed consent and follow the study procedure. 3. Has not participated in a similar investigation in the past four weeks. 4. Subjects willing to refrain taking any other anti-viral medication during the study period
Exclusion criteria
Exclusion criteria: 1. Subjects with clinically significant serious cardiovascular cerebrovascular, respiratory, hepatic, renal disease, congenital or any other disorder. 2. A known history or present condition of allergic response to pharmaceutical products its components or ingredients in the test product. 3. Pre-existing systemic disease necessitating long-term medications. 4. Genetic and endocrinal disorders. 5. Subjects who refused to sign informed consent. 6. Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Occurrence of any adverse or serious adverse events during the study period.Timepoint: Visit 1 / Day 1 Visit 2 / Day 4 | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall compliance of the subject to the study medicationTimepoint: Visit 1 / Day 1 Visit 2 / Day 4 | — |
Countries
India
Contacts
Himalaya Wellness Company